Yossi Maimon

No open positions remaining

55 year

Health Technology

Consumer Services

Profile

Yossi Maimon formerly worked at ColBar LifeScience Ltd., as Chief Financial Officer from 2002 to 2006, Protalix Biotherapeutics, Inc., as CFO, Secretary, Treasurer & Vice President from 2012 to 2019, Protalix Ltd., as Chief Financial Officer, and Old Ayala, Inc., as Chief Financial Officer, Secretary & Treasurer.
Mr. Maimon received his undergraduate degree from City University of New York and Masters Business Admin degree from Tel-Aviv University.

Former positions of Yossi Maimon

Companies	Position	End
ADVAXIS, INC.	Director of Finance/CFO	18/01/2023
PROTALIX BIOTHERAPEUTICS, INC.	Director of Finance/CFO	21/07/2019
ColBar LifeScience Ltd. ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology Develops technology for tissue regeneration and tissue engineering	Director of Finance/CFO	31/12/2005
Protalix Ltd.	Director of Finance/CFO	-

See the detail of Yossi Maimon's experience

Training of Yossi Maimon

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yossi Maimon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
City University of New York City University of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Tel-Aviv University Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ColBar LifeScience Ltd. ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology Develops technology for tissue regeneration and tissue engineering	Health Technology
Protalix Biotherapeutics, Inc. Protalix Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets recombinant therapeutic proteins	Health Technology
Protalix Ltd.
Old Ayala, Inc. Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company which develops cancer therapies	Health Technology